论文信息 - Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer - 字舞流文

Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer

E. Warren | Shashidhar Ravishankar | N. Ramnath | Andrea M. H. Towlerton | Cindy Y Jiang | Lili Zhao | Michael D Green | Anthony J Scott | Malini Raghavan | Matthew F Cusick | Matthew F. Cusick